Armo Biosciences Inc. (ARMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 42,671 | 33,761 | 27,491 |
| Operating Income | -42,671 | -33,761 | -27,491 |
| Other Income | 246 | 137 | 21 |
| Pre-tax Income | -42,425 | -33,624 | -27,470 |
| Net Income Continuous | -42,425 | -33,624 | -27,470 |
| Minority Interests | N/A | N/A | -2,488 |
| Net Income | $-42,425 | $-33,624 | $-24,982 |
| EPS Basic Total Ops | -28.52 | -26.25 | -30.59 |
| EPS Basic Continuous Ops | -28.53 | -26.25 | -33.62 |
| EPS Diluted Total Ops | -28.52 | -26.25 | -30.59 |
| EPS Diluted Continuous Ops | -28.53 | -26.25 | -33.62 |
| EPS Diluted Before Non-Recurring Items | -28.52 | N/A | N/A |
| EBITDA(a) | $-42,471 | $-33,554 | $-27,287 |